ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	19 October 2017
Main ID:	NCT00798889
Date of registration:	25/11/2008
Prospective Registration:	No
Primary sponsor:	Pfizer
Public title:	Rollover Protocol for Prior SU011248 Protocols
Scientific title:	A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol
Date of first enrolment:	March 2004
Target sample size:	314
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT00798889
Study type:	Interventional
Study design:
Phase:	N/A

Countries of recruitment
Australia	Canada	France	Greece	Italy	Netherlands	Singapore	Sweden
Switzerland	United Kingdom	United States

Contacts

Name:	Pfizer CT.gov Call Center
Address:
Telephone:
Email:
Affiliation:	Pfizer

Key inclusion & exclusion criteria

Inclusion Criteria:

- Prior SU011248 Protocol.

- Eligible to continue SU011248 treatment.

Exclusion Criteria:

- Uncontrolled CNS metastasis.

- Unfit to receive SU011248.

Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Solid Tumors

Intervention(s)

Drug: Sunitinib

Primary Outcome(s)

Duration of Treatment [Time Frame: Baseline up to Day 28 after last dose of study treatment]

Secondary Outcome(s)

Secondary ID(s)

A6181030

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:	Yes
Date Posted:	21/01/2013
Date Completed:
URL:	https://clinicaltrials.gov/ct2/show/results/NCT00798889

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.